CORMEDIX INC (CRMD) Stock Income Statement
NASDAQ:CRMD - Nasdaq - US21900C3088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 82.55M | 43.47M | 0.00 | 70.00K | 190.00K | |||
| Cost Of Goods | 3.97M | 3.19M | 0.00 | 0.00 | 150.00K | |||
| Gross Profit | 78.59M | 40.28M | 0.00 | 60.00K | 40.00K | |||
| Operating Expenses | 64.11M | 62.64M | 48.96M | 30.69M | 29.48M | |||
| Research and Development | 6.30M | 3.94M | 13.16M | 10.68M | 13.13M | |||
| Selling, General, and Administrative Expenses | 57.81M | 58.70M | 35.80M | 20.01M | 16.35M | |||
| Operating Income | 14.47M | -22.36M | -48.96M | -30.62M | -29.44M | |||
| Interest Income/Expense | 2.19M | 2.51M | 2.62M | 340.00K | -20.00K | |||
| Other Income/Expense | N/A | 520.00K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 17.18M | -19.32M | -46.34M | -30.29M | -29.46M | |||
| Income Tax | 0.00 | -1.39M | 0.00 | -590.00K | -1.25M | |||
| Net Income | 17.18M | -17.93M | -46.34M | -29.70M | -28.21M | |||
| EBITDA | 14.92M | -22.05M | -48.89M | -30.54M | -29.38M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.23 | -0.30 | -0.91 | -0.74 | -0.75 | |||
| Non GAAP EPS | 0.22 | -0.33 | -0.92 | -0.74 | -0.74 | |||
| Statistics | ||||||||
| Gross Profit Margin | 95.19% | 92.66% | N/A | 85.71% | 21.05% | |||
| Profit Margin | 20.81% | -41.24% | N/A | -42428.57% | -14847.37% | |||
| Operating Profit Margin | 17.53% | -51.43% | N/A | -43742.86% | -15494.74% | |||
All data in USD